137 related articles for article (PubMed ID: 25188871)
1. Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptor.
Davie BJ; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
ACS Chem Neurosci; 2014 Oct; 5(10):902-7. PubMed ID: 25188871
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.
Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
[TBL] [Abstract][Full Text] [Related]
4. Probing the binding site of novel selective positive allosteric modulators at the M
Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A
J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568
[TBL] [Abstract][Full Text] [Related]
7. A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
Shirey JK; Brady AE; Jones PJ; Davis AA; Bridges TM; Kennedy JP; Jadhav SB; Menon UN; Xiang Z; Watson ML; Christian EP; Doherty JJ; Quirk MC; Snyder DH; Lah JJ; Levey AI; Nicolle MM; Lindsley CW; Conn PJ
J Neurosci; 2009 Nov; 29(45):14271-86. PubMed ID: 19906975
[TBL] [Abstract][Full Text] [Related]
8. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
[TBL] [Abstract][Full Text] [Related]
9. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
[TBL] [Abstract][Full Text] [Related]
10. Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.
Hadac EM; Dawson ES; Darrow JW; Sugg EE; Lybrand TP; Miller LJ
J Med Chem; 2006 Feb; 49(3):850-63. PubMed ID: 16451051
[TBL] [Abstract][Full Text] [Related]
11. A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation.
Canals M; Lane JR; Wen A; Scammells PJ; Sexton PM; Christopoulos A
J Biol Chem; 2012 Jan; 287(1):650-659. PubMed ID: 22086918
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
[TBL] [Abstract][Full Text] [Related]
13. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
14. Development of Photoactivatable Allosteric Modulators for the Chemokine Receptor CXCR3.
Admas TH; Bernat V; Heinrich MR; Tschammer N
ChemMedChem; 2016 Mar; 11(6):575-84. PubMed ID: 26880380
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of M4 muscarinic receptor positive allosteric modulators derived from VU10004.
Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B
ACS Chem Neurosci; 2015 Jun; 6(6):838-44. PubMed ID: 25857219
[TBL] [Abstract][Full Text] [Related]
16. Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.
Chen X; Klöckner J; Holze J; Zimmermann C; Seemann WK; Schrage R; Bock A; Mohr K; Tränkle C; Holzgrabe U; Decker M
J Med Chem; 2015 Jan; 58(2):560-76. PubMed ID: 25478907
[TBL] [Abstract][Full Text] [Related]
17. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
